Madrigal Pharmaceuticals
Madrigal Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with significant unmet medical needs. The company has achieved a breakthrough by securing the first FDA-approved treatment for MASH, aiming to halt or reverse liver scarring and prevent severe complications.
Focused on delivering transformative care, Madrigal seeks to improve the lives of those affected by MASH and is committed to advancing research in this critical area of liver health. The company recognizes the urgent need for effective treatment, as MASH is becoming a leading cause of liver transplantation among both men and women in the United States.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.